. 2021 Sep 25;21:505. doi: 10.1186/s12877-021-02393-6

Table 3.

Hazard ratio and 95%CI of CVD for MetS and the number of components of MetS by the NCEP, AHA/NHLBI and IDF criteria in elderly female from rural China

	CHD(n=54)	Stroke(n=85)	CVD(n=119)
MetS by different criteria (ref=non- MetS)
NCEP ATP III	1.38 (0.80,2.37)	1.27 (0.73,2.21)	1.52 (0.99,2.33)	1.54 (0.99,2.40)	1.45 (1.02,2.08)	1.45 (1.00, 2.10)
AHA/NHLBI	1.41 (0.82,2.44)	1.33 (0.77,2.32)	1.42 (0.93,2.18)	1.44 (0.92,2.25)	1.35 (0.94,1.93)	1.36 (0.94, 1.97)
IDF	1.09 (0.64,1.88)	1.10 (0.89,1.36)	1.56 (1.01,2.41)	1.62 (1.03,2.55)	1.36 (0.95,1.95)	1.36 (0.93, 1.97)
Metabolic components (ref= no)
Elevated Blood pressure	2.06 (0.82,5.21)	1.69 (0.66,4.33)	1.43 (0.76,2.70)	1.29 (0.67,2.45)	1.49 (0.87,2.56)	1.31 (0.76,2.28)
Hypertriglycerides	1.12 (0.65,1.93)	1.12 (0.65,1.94)	1.03 (0.67,1.60)	1.05 (0.67,1.64)	1.20 (0.84,1.73)	1.22 (0.84,1.76)
Low HDL-C	1.38 (0.81,2.37)	1.38 (0.80,2.39)	1.21 (0.79,1.86)	1.30 (0.83,2.03)	1.31 (0.91,1.87)	1.42 (0.98,2.05)
Abdominal obesity (NCEP ATP III and AHA/NHLBI) ^a	1.04 (0.58,1.87)	0.95 (0.52,1.72)	1.55 (1.00,2.41)	1.60 (1.01,2.52)	1.20 (0.82,1.76)	1.18 (0.80,1.75)
Abdominal obesity (IDF) ^b	1.05 (0.60,1.84)	0.97 (0.55,1.71)	1.46 (0.93,2.31)	1.41 (0.88,2.25)	1.25 (00.86,1.82)	1.18 (0.80,1.73)
High FPG (NCEP ATP III) ^c	0.76 (0.41,1.40)	0.75 (0.40,1.39)	1.34 (0.86,2.08)	1.32 (0.83,2.11)	1.19 (0.81,1.73)	1.18 (0.80,1.75)
High FPG (AHA/NHLBI and IDF) ^d	0.94 (0.55,1.61)	0.99 (0.57,1.72)	1.33 (0.85,2.06)	1.36 (0.86,2.16)	1.25 (0.86,1.80)	1.30 (0.89,1.90)

CHD(n=54)

Stroke(n=85)

CVD(n=119)

Crude HR (95%CI)

Adjusted HR (95%CI)

Crude HR (95%CI)

Adjusted HR (95%CI)

Crude HR (95%CI)

Adjusted HR (95%CI)

MetS by different criteria (ref=non- MetS)

NCEP ATP III

1.38

(0.80,2.37)

1.27

(0.73,2.21)

1.52

(0.99,2.33)

1.54

(0.99,2.40)

1.45

(1.02,2.08)

1.45

(1.00, 2.10)

AHA/NHLBI

1.41

(0.82,2.44)

1.33

(0.77,2.32)

1.42

(0.93,2.18)

1.44

(0.92,2.25)

1.35

(0.94,1.93)

1.36

(0.94, 1.97)

IDF

1.09

(0.64,1.88)

1.10

(0.89,1.36)

1.56

(1.01,2.41)

1.62

(1.03,2.55)

1.36

(0.95,1.95)

1.36

(0.93, 1.97)

Metabolic components (ref= no)

Elevated Blood pressure

2.06

(0.82,5.21)

1.69

(0.66,4.33)

1.43

(0.76,2.70)

1.29

(0.67,2.45)

1.49

(0.87,2.56)

1.31

(0.76,2.28)

Hypertriglycerides

1.12

(0.65,1.93)

1.12

(0.65,1.94)

1.03

(0.67,1.60)

1.05

(0.67,1.64)

1.20

(0.84,1.73)

1.22

(0.84,1.76)

Low HDL-C

1.38

(0.81,2.37)

1.38

(0.80,2.39)

1.21

(0.79,1.86)

1.30

(0.83,2.03)

1.31

(0.91,1.87)

1.42

(0.98,2.05)

Abdominal obesity (NCEP ATP III and AHA/NHLBI) ^a

1.04

(0.58,1.87)

0.95

(0.52,1.72)

1.55

(1.00,2.41)

1.60

(1.01,2.52)

1.20

(0.82,1.76)

1.18

(0.80,1.75)

Abdominal obesity (IDF) ^b

1.05

(0.60,1.84)

0.97

(0.55,1.71)

1.46

(0.93,2.31)

1.41

(0.88,2.25)

1.25

(00.86,1.82)

1.18

(0.80,1.73)

High FPG (NCEP ATP III) ^c

0.76

(0.41,1.40)

0.75

(0.40,1.39)

1.34

(0.86,2.08)

1.32

(0.83,2.11)

1.19

(0.81,1.73)

1.18

(0.80,1.75)

High FPG (AHA/NHLBI and IDF) ^d

0.94

(0.55,1.61)

0.99

(0.57,1.72)

1.33

(0.85,2.06)

1.36

(0.86,2.16)

1.25

(0.86,1.80)

1.30

(0.89,1.90)

Adjusted for sex, age, marital status, education, physical activity, currently smoking (yes, no), currently drinking (yes, no), family history of CHD, family history of stroke and family history of hypertension.

^a Waist circumference ≥102 cm in men and ≥88 cm in women.

^b Waist circumference ≥90 cm in men and ≥80 cm in women.

^c Fasting glucose level of ≥6.1 mmol/L.

^d Fasting glucose level of ≥5.6 mmol/L.